MYC and chronic myelogenous leukemia, BCR-ABL1 positive: The role of this kinase activity differs from that in HSCs, where BCR-ABL1 phosphorylates β-catenin, giving rise to initial forms of chronic myeloid leukemia (CML), without requiring MYC induction [58,59].